Therapeutic Area | MeSH |
---|---|
infections | D007239 |
urogenital diseases | D000091642 |
immune system diseases | D007154 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RETROVIR | ViiV Healthcare | N-019655 RX | 1987-03-19 | 1 products, RLD, RS |
RETROVIR | ViiV Healthcare | N-019910 RX | 1989-09-28 | 1 products, RLD, RS |
RETROVIR | ViiV Healthcare | N-019951 RX | 1990-02-02 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LAMIVUDINE, NEVIRAPINE AND ZIDOVUDINE | Micro Laboratories | N-205626 DISCN | 2018-08-13 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LAMIVUDINE AND ZIDOVUDINE | PharmaCare | N-022018 DISCN | 2017-03-17 | 1 products |
COMBIVIR | ViiV Healthcare | N-020857 DISCN | 1997-09-26 | 1 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
TRIZIVIR | ViiV Healthcare | N-021205 DISCN | 2000-11-14 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
abacavir sulfate, lamivudine and zidovudine | ANDA | 2013-12-17 |
abacavir, lamivudine and zidovudine | ANDA | 2023-10-31 |
azactam | New Drug Application | 2025-01-09 |
aztreonam | ANDA | 2024-06-03 |
cayston | New Drug Application | 2025-03-17 |
combivir | New Drug Application | 2023-08-22 |
compound w | C200263 | 2024-10-25 |
compound w for kids one step strips | C200263 | 2024-10-25 |
compound w one step pads | C200263 | 2024-10-25 |
compound w one step plantar foot pads | C200263 | 2024-10-25 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
hiv infections | EFO_0000764 | D015658 | B20 |
acquired immunodeficiency syndrome | EFO_0000765 | D000163 | B20 |
hepatitis b | — | D006509 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | — | — | — | 1 |
Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 1 | — | — | — | 1 |
Drug common name | Zidovudine |
INN | zidovudine |
Description | Zidovudine is a pyrimidine 2',3'-dideoxyribonucleoside compound having a 3'-azido substituent and thymine as the nucleobase. It has a role as an antiviral drug, an antimetabolite and a HIV-1 reverse transcriptase inhibitor. It is a pyrimidine 2',3'-dideoxyribonucleoside and an azide. |
Classification | Small molecule |
Drug class | antineoplastics; antivirals (zidovudine group) (exception: edoxudine) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O |
PDB | — |
CAS-ID | 30516-87-1 |
RxCUI | — |
ChEMBL ID | CHEMBL129 |
ChEBI ID | 10110 |
PubChem CID | 35370 |
DrugBank | DB00495 |
UNII ID | 4B9XT59T7S (ChemIDplus, GSRS) |